OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
Ruoning Yang, Yueyi Li, Hang Wang, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 74
Ruoning Yang, Yueyi Li, Hang Wang, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1796-1796
Open Access | Times Cited: 134
Onyinyechi Obidiro, Gantumur Battogtokh, Emmanuel O. Akala
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1796-1796
Open Access | Times Cited: 134
Advancing triple-negative breast cancer treatment through peptide decorated solid lipid nanoparticles for paclitaxel delivery
Tahereh Rahdari, Mohsen Mahdavimehr, Hossein Ghafouri, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Tahereh Rahdari, Mohsen Mahdavimehr, Hossein Ghafouri, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 4
The Mechanism of DNA Methylation and miRNA in Breast Cancer
Lingyuan Ma, Chenyu Li, Hanlin Yin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9360-9360
Open Access | Times Cited: 37
Lingyuan Ma, Chenyu Li, Hanlin Yin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9360-9360
Open Access | Times Cited: 37
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 10
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 10
Targeting Receptor Tyrosine Kinases as a Novel Strategy for the Treatment of Triple-Negative Breast Cancer
Sara K. Jaradat, Nehad M. Ayoub, Ahmed H. Al Sharie, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 9
Sara K. Jaradat, Nehad M. Ayoub, Ahmed H. Al Sharie, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access | Times Cited: 9
The Importance of Being Casiopeina as Polypharmacologycal Profile (Mixed Chelate–Copper (II) Complexes and Their In Vitro and In Vivo Activities)
Zenayda Aguilar-Jiménez, Adrián Espinoza-Guillén, Karen Reséndiz-Acevedo, et al.
Inorganics (2023) Vol. 11, Iss. 10, pp. 394-394
Open Access | Times Cited: 21
Zenayda Aguilar-Jiménez, Adrián Espinoza-Guillén, Karen Reséndiz-Acevedo, et al.
Inorganics (2023) Vol. 11, Iss. 10, pp. 394-394
Open Access | Times Cited: 21
Antitumor Mechanisms of Molecules Secreted by Trypanosoma cruzi in Colon and Breast Cancer: A Review
Soheil Sadr, Shakila Ghiassi, Narges Lotfalizadeh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 15, pp. 1710-1721
Closed Access | Times Cited: 20
Soheil Sadr, Shakila Ghiassi, Narges Lotfalizadeh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 15, pp. 1710-1721
Closed Access | Times Cited: 20
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 8
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 8
Photothermal Ferrotherapy – Induced Immunogenic Cell Death via Iron‐Based Ternary Chalcogenide Nanoparticles Against Triple‐Negative Breast Cancer
Qiang Wu, Zhuoyuan Li, Xin Zhou, et al.
Small (2023) Vol. 20, Iss. 20
Closed Access | Times Cited: 13
Qiang Wu, Zhuoyuan Li, Xin Zhou, et al.
Small (2023) Vol. 20, Iss. 20
Closed Access | Times Cited: 13
New isoxazoline‐linked 1,3,4‐thiadiazole derivatives: synthesis, antiproliferative activity, molecular docking, molecular dynamics and DFT
Yassine Laamari, Muhammed Tılahun Muhammed, Ali Irfan, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139368-139368
Closed Access | Times Cited: 5
Yassine Laamari, Muhammed Tılahun Muhammed, Ali Irfan, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139368-139368
Closed Access | Times Cited: 5
Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis
Alessandro Rizzo, Francesca Matilde Schipilliti, Francesco Di Costanzo, et al.
ESMO Open (2023) Vol. 8, Iss. 6, pp. 102198-102198
Open Access | Times Cited: 11
Alessandro Rizzo, Francesca Matilde Schipilliti, Francesco Di Costanzo, et al.
ESMO Open (2023) Vol. 8, Iss. 6, pp. 102198-102198
Open Access | Times Cited: 11
Peptide-Modified Cyclodextrin-Based Nanosystem for Co-Delivery of Celastrol and siPD-L1 to Tumors
Dongna Wang, Tianyu Zhang, Yixue Hu, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 10, pp. 11432-11444
Closed Access | Times Cited: 4
Dongna Wang, Tianyu Zhang, Yixue Hu, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 10, pp. 11432-11444
Closed Access | Times Cited: 4
Evaluating the Anticancer Effects of Carnosic Acid Against Breast Cancer: An In Vitro Investigation
Aylar Borhan, Ali Bagherlou, Mohammad B Ghayour
Tissue and Cell (2025) Vol. 93, pp. 102718-102718
Closed Access
Aylar Borhan, Ali Bagherlou, Mohammad B Ghayour
Tissue and Cell (2025) Vol. 93, pp. 102718-102718
Closed Access
Discovery of a Novel Selective and Cell-Active N6-Methyladenosine RNA Demethylase ALKBH5 Inhibitor
Xianyuan Yang, K. X. Huang, Xu-Nian Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Xianyuan Yang, K. X. Huang, Xu-Nian Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities
Qiuming Pan, Zhu Ye, Zhi Ting Ye, et al.
BMEMat (2025)
Open Access
Qiuming Pan, Zhu Ye, Zhi Ting Ye, et al.
BMEMat (2025)
Open Access
Novel Combination therapy of Osimertinib and Tupichinol E in Triple-Negative Breast Cancer: Targeting EGFR and CDK4/6 Pathways
Adyasa Samantaray, Debasish Pradhan
Aspects of Molecular Medicine (2025), pp. 100069-100069
Open Access
Adyasa Samantaray, Debasish Pradhan
Aspects of Molecular Medicine (2025), pp. 100069-100069
Open Access
A Supramolecular, Triple Negative Breast Cancer‐Targeting Avidin‐Photosensitizer
Bingjie Gao, Christoph Schäfers, Seah Ling Kuan, et al.
Macromolecular Bioscience (2025)
Open Access
Bingjie Gao, Christoph Schäfers, Seah Ling Kuan, et al.
Macromolecular Bioscience (2025)
Open Access
Deciphering multifaceted molecular mechanisms of matairesinol in inhibiting triple-negative breast cancer through comprehensive systems biology investigations
Amol Chaudhary, Nidhi Sharma, Amrita Ulhe, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-26
Closed Access
Amol Chaudhary, Nidhi Sharma, Amrita Ulhe, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-26
Closed Access
Bimetallic chitosan/hyaluronic acid nanoparticles self-amplify ferroptosis/cuproptosis in triple-negative breast cancer
Juan Wang, Junyu Wang, Jun Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 142535-142535
Closed Access
Juan Wang, Junyu Wang, Jun Zhang, et al.
International Journal of Biological Macromolecules (2025), pp. 142535-142535
Closed Access
Eco-Friendly Nanotherapeutics: Metallic Nanoparticles for Targeting Breast Cancer
Darakhshan Javaid, Shahid Yousuf Ganie, Syed Sanober Qadri, et al.
European Journal of Pharmacology (2025), pp. 177603-177603
Closed Access
Darakhshan Javaid, Shahid Yousuf Ganie, Syed Sanober Qadri, et al.
European Journal of Pharmacology (2025), pp. 177603-177603
Closed Access
Discovery and biological evaluation of a novel and highly potent JAK2 inhibitor for the treatment of triple negative breast cancer
Ying Miao, Shudan Yang, Fang Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Ying Miao, Shudan Yang, Fang Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
Soyoung Kim, Ilseob Choi, Ik‐Hwan Han, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15751-15751
Open Access | Times Cited: 18
Soyoung Kim, Ilseob Choi, Ik‐Hwan Han, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15751-15751
Open Access | Times Cited: 18
Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1829-1842
Open Access | Times Cited: 17
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1829-1842
Open Access | Times Cited: 17
Identification of Breast Cancer Subtypes by Integrating Genomic Analysis with the Immune Microenvironment
Ran Ding, Qiwei Liu, Jing Yu, et al.
ACS Omega (2023) Vol. 8, Iss. 13, pp. 12217-12231
Open Access | Times Cited: 10
Ran Ding, Qiwei Liu, Jing Yu, et al.
ACS Omega (2023) Vol. 8, Iss. 13, pp. 12217-12231
Open Access | Times Cited: 10
Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer
Christos Damaskos, Iason Psilopatis, Anna Garmpi, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 209-209
Open Access | Times Cited: 3
Christos Damaskos, Iason Psilopatis, Anna Garmpi, et al.
Cancers (2024) Vol. 16, Iss. 1, pp. 209-209
Open Access | Times Cited: 3
